S. Boesgaard et al., THIOLS AND NITRATES - REEVALUATION OF THE THIOL DEPLETION THEORY OF NITRATE TOLERANCE, The American journal of cardiology, 81(1A), 1998, pp. 21-29
Organic nitrates like nitroglycerin are widely used in the treatment o
f ischemic heart disease. The magnitude and duration of their circulat
ory and anti-ischemic effects are, however, rapidly reduced during con
tinuous treatment. Although the exact enzymatic mechanism responsible
for the bioactivation of nitrates has not been defined, it is clear th
at their pharmacodynamic effects depend strongly on intracellular thio
l levels. Based on in vitro experiments, it was subsequently hypothesi
zed that nitrate tolerance is caused by reduced bioconversion of nitra
tes to nitric oxide (NO) and that depletion of intracellular thiol com
pounds might be responsible for this process (the thiol depletion theo
ry of nitrate tolerance). This hypothesis has, however, not been confi
rmed in recent in vivo studies showing that the vascular nitroglycerin
derived NO formation is similar in tissues from nontolerant and nitra
te tolerant rats and that hemodynamic nitrate tolerance develops witho
ut any indication of thiol depletion, Thus, reduced biologic activity
of NO, rather than thiol-mediated reduced bioconversion of nitrates to
NO, may contribute to in vivo tolerance development, On the other sid
e, exogenous thiol administration augments the hemodynamic response to
nitrates. This effect is not tolerance specific and thiols, per se, a
lso have the potential to affect a wide range of physiologic reactions
occurring during prolonged nitrate exposure (e.g., via antioxidant ef
fects or angiotensin-converting enzyme inhibition). (C) 1998 by Excerp
ta Medica, Inc.